4.75Open4.75Pre Close0 Volume0 Open Interest22.00Strike Price0.00Turnover299.43%IV4.54%PremiumSep 20, 2024Expiry Date3.93Intrinsic Value100Multiplier3DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type-0.7066Delta0.0666Gamma3.80Leverage Ratio-0.2760Theta-0.0015Rho-2.69Eff Leverage0.0059Vega
Teva Pharmaceutical Industries Stock Discussion
Jefferies analysts cited 10 possible policies that Tr...
Polls Show Harris Leading Trump
According to the latest polling by The New York Times and Siena College, Harris leads Trump by fo...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX – Research Report), Eli Lilly & Co (LLY – Research Report) and Teva Pharmaceutical (TEVA – Research Report) with bullish sentiments.
Immuneering (IMRX)
In a report issued on A...
$Air Products & Chemicals (APD.US)$ : “You really don’t want to be in Air Products, you want to be in Linde. Linde’s a much better run company, and that’s why Air Products isn’t doing as well , and Linde’s doing spectacularly.”
$Sarepta Therapeutics (SRPT.US)$ : “I think Sarepta is a speculative situation where they have great science. ...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
No comment yet